Skip to main content

Day: September 7, 2021

NEW GLUCODOWN® “ENHANCED WATER” BEVERAGES LAUNCH TODAY AT AMAZON — SPECIAL LOYALTY DISCOUNT IN EFFECT UNTIL FRIDAY

BENTONVILLE, AR, Sept. 07, 2021 (GLOBE NEWSWIRE) — Glucose Health, Inc. (OTC Pink: GLUC) (“Company”) is pleased to announce today, after 16 months of product development, new GLUCODOWN® “enhanced water” drink mixes are now available for purchase at Amazon.  GLUCODOWN® Diabetic Friendly Beverage, Delicious Cherry GLUCODOWN® Diabetic Friendly Beverage, Delicious Peach Mango GLUCODOWN® Diabetic Friendly Beverage, Delicious Watermelon GLUCODOWN® Diabetic Friendly Beverage, Delicious Strawberry BananaGLUCODOWN® is the first non-dairy beverage in North America enriched with a special form of soluble fiber clinically demonstrated to help maintain healthy blood sugar (and regular digestive health). With its diabetic friendly nutritional profile of No Sugar, No Caffeine and Good Source of Fiber, GLUCODOWN® is a healthy...

Continue reading

The Limestone Boat Company Names Pete Pigott as Chief Financial Officer

Mr. Pete Pigott is an accomplished executive partner with significant capital markets successes in his career, raising over $500 million and leading three IPOs COLLINGWOOD, Ontario, Sept. 07, 2021 (GLOBE NEWSWIRE) — The Limestone Boat Company Limited (“Limestone”) (TSXV: BOAT) – owner and builder of Aquasport Boats, Limestone® Boats and Boca Bay Boats – is pleased to announce the appointment of Mr. Peter Pigott, CPA, CA as Chief Financial Officer. Mr. Pigott has over 35 years of experience in finance with a diverse group of entrepreneurial growth companies and dominant brands, both private and public, wherein he played an instrumental role in their successes. Mr. Pigott is a seasoned leader with an accomplished capital markets background, spearheading the successful Initial Public Offerings of Sleep Country Canada and West 49,...

Continue reading

MEDIA ADVISORY: Ultragenyx Canada Announces Health Canada Approval of a Second Indication for Crysvita™ (Burosumab Injection) for the Treatment of Tumour Induced Osteomalacia in Adults

Dr. Aliya Khan QuoteA quote from Dr. Aliya Khan, Professor of Clinical Medicine, Divisions of Endocrinology and Metabolism and Geriatrics; Director of Fellowship in Metabolic Bone Disease and Director of the Calcium Disorders Clinic at McMaster University.OTTAWA, Sept. 07, 2021 (GLOBE NEWSWIRE) — Ultragenyx Pharmaceutical Inc., a biopharmaceutical company focused on the development and commercialization of novel products for rare and ultra-rare diseases, today announced that Crysvita™ (Burosumab Injection) has been approved by Health Canada for the treatment of Tumour Induced Osteomalacia (TIO) in adults. Crysvita is also approved for the treatment of X-Linked Hypophosphatemia. TIO is a rare disease that is characterized by the development of tumours that cause weakened and softened bones. The tumours associated...

Continue reading

Vintage Wine Estates, Inc. Announces Fourth Quarter and Fiscal Year 2021 Earnings Date and Conference Call

SANTA ROSA, Calif., Sept. 07, 2021 (GLOBE NEWSWIRE) — Vintage Wine Estates, Inc. (NASDAQ: VWE) (TSX: VWE.U) (TSX: VWE.WT.U) (“VWE” or the “Company”), one of the fastest growing U.S. wine producers with an industry leading direct-to-customer platform, today announced that the Company will conduct a conference call to discuss its Fourth Quarter and Fiscal Year 2021 financial results on Wednesday, September 22, 2021 at 4:30 PM Eastern Time. The call will feature remarks by VWE’s management team. Investors interested in participating in the live call can dial 844-200-6205 or 646-904-5544 and use the access code 925261. There will also be a simultaneous, live webcast available on the Investor Relations section of the Company’s website at https://ir.vintagewineestates.com/. The webcast will be archived as well for replay. About...

Continue reading

Global Crossing Airlines to Participate in Cowen’s 14th Annual Global Transportation and Sustainable Mobility Conference

MIAMI, Sept. 07, 2021 (GLOBE NEWSWIRE) — Global Crossing Airlines Group Inc. (JET: TSX-V; JET.B: TSX-V; JETMF: OTCQB) (the “Company” or “GlobalX”) has been invited to participate in a fireside chat at Cowen’s 14th Annual Global Transportation and Sustainable Mobility Conference. GlobalX’s Founder and CEO, Ed Wegel will sit down with Cowen Managing Director, Helane Becker. Ms. Becker is Cowen’s senior research analyst for airlines, air freight, and aircraft leasing. The conversation will begin on Friday, September 10th   at 10:40 AM EDT. Cowen will be webcasting the audio presentation live and a link to the webcast is below: https://wsw.com/webcast/cowen100/jetmf/2165502 About Global Crossing Airlines GlobalX is a US 121 domestic flag and supplemental airline flying the Airbus A320 family aircraft. GlobalX flies as an ACMI...

Continue reading

Kala Pharmaceuticals to Present at Upcoming Investor Conferences in September 2021

WATERTOWN, Mass., Sept. 07, 2021 (GLOBE NEWSWIRE) — Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye, today announced that management will participate in the following virtual healthcare investor conferences in September 2021: H.C. Wainwright 23rd Annual Global Investment ConferenceA pre-recorded presentation will be made available beginning Monday, September 13, 2021 at 7:00 a.m. ET. Cantor Global Healthcare Conference 2021A pre-recorded presentation will be made available beginning Tuesday, September 28, 2021 at 4:40 p.m. ET. Management will also be available for virtual 1×1 meetings on the same day as each presentation. To access the webcasts and subsequent archived recording...

Continue reading

Snap One Holdings Corp. to Present at the 10th Annual Gateway Conference on September 9, 2021

CHARLOTTE, N.C., Sept. 07, 2021 (GLOBE NEWSWIRE) — Snap One Holdings Corp. (NASDAQ: SNPO) (“Snap One” or the “Company”), a provider of smart living products, services and software to professional integrators, has been invited to present at the 10th Annual Gateway Conference, which is being held virtually on September 8-9, 2021. Snap One management is scheduled to present on Thursday, September 9th at 12:00 p.m. Pacific time, with one-on-one meetings to be held throughout the conference. The presentation will be webcast live and available for replay here. To receive additional information, request an invitation or to schedule a one-on-one meeting, please email conference@gatewayir.com. About the Gateway Conference For the past nine years, the Gateway Conference has engaged the management teams of nearly 800 public and private growth...

Continue reading

Ann Summers and OOOOO Join Forces to Launch Interactive Video Commerce in UK for Lingerie and Sexual Wellness

VANCOUVER, British Columbia, Sept. 07, 2021 (GLOBE NEWSWIRE) — OOOOO Entertainment Commerce Limited (“OOOOO” or the “Company”) (OOOO:TSXV), a mobile commerce platform, is pleased to announce that Ann Summers, a British multinational retailer, has joined OOOOO’s platform. Ann Summers is a reputable, iconic brand committed in its mission to push boundaries & buttons to give customers exactly what they want. OOOOO is interactive, live live-stream shopping app that allows brands to engage and sell to consumers in a new way. This pioneering partnership brings together a like-minded, progressive ethos – connecting customers direct to the source of expertise and curated collections of lingerie and adult toys via OOOOO’s interactive mobile commerce platform. Since launch in July, Ann Summers’s four shows have demonstrated appeal...

Continue reading

POINT Biopharma to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

INDIANAPOLIS, Sept. 07, 2021 (GLOBE NEWSWIRE) — POINT Biopharma Global Inc. (NASDAQ: PNT) (the “Company” or “POINT”), a company accelerating the discovery, development and global access to life changing radiopharmaceuticals, today announced that the Company’s Chief Executive Officer, Dr. Joe McCann will present at the H.C. Wainwright 23rd Annual Global Investment Conference, being held from September 13-15, 2021. A webcast of the presentation will be made available at 7:00am ET on Monday, September 13, 2021. The recording will be available on the Company’s website, www.pointbiopharma.com, under “News” in the investors section. An archived replay of the webcast will be available for approximately 30 days. About POINT Biopharma Global Inc.POINT Biopharma Global Inc. is a globally focused radiopharmaceutical company building a platform...

Continue reading

MIMEDX to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

MARIETTA, Ga., Sept. 07, 2021 (GLOBE NEWSWIRE) — MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), an industry leader in utilizing amniotic tissue as a platform for regenerative medicine, today announced that Timothy R. Wright, Chief Executive Officer, Peter M. Carlson, Chief Financial Officer, and Robert B. Stein, M.D., Ph.D., Executive Vice President, Research and Development, will present at the H.C. Wainwright 23rd Annual Global Investment Conference held on September 13 – 15, 2021. The presentation will be available on the Events page of the Investors section of the Company’s website at www.mimedx.com, or by clicking here, beginning on Monday, September 13, 2021 at 7:00 AM Eastern Time and will be accessible for approximately 90 days. About MIMEDXMIMEDX is an industry leader in utilizing amniotic tissue...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.